Varicella and herpes zoster can be serious or even fatal diseases in immunocompromised patients. However, they can be prevented or markedly attenuated by the administration of zoster-immune globulin (ZIG) or zoster-immune plasma (ZIP), but there is no established treatment once these disorders have occurred. Eight such patients were treated with ZIP, with promising results.
All Keywords